Traumatic brain injury is a major cause of mortality and disability. TBI secondary intracranial hemorrhage is associated with a greater risk of coagulopathy which increases risk of bleeding development and higher mortality. Antifibrinolytic operatives like tranexamic acid (TA) might reduce traumatic ICH. The study purpose is to investigate the effect of TXA on primary outcome, intracranial haemorrhage growth after hospital admission up-to 48 hrs. The results presented here are, to inform about the effect of tranexamic acid in traumatic intracranial bleeding. The findings will include some reassurance about tranexamic acid protection in these patients. Many studies of the influence of tranexamic acid on intracranial recurrent bleeding.